
Sitagliptin
|
CAS Registry Number |
|
IUPAC
Name (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine |
|
|
Administration Route |
Active Substance |
Unit Dosage |
|
|
TABLET |
ORAL |
SITAGLIPTIN PHOSPHATE MONOHYDRATE |
25, 50, 100 MG |
|
Original Brand Name |
JANUVIA
(MSD) |
|
|
Excipients |
TABLET
Core: |
Microcrystalline
cellulose, Calcium hydrogen phosphate anhydrous,
Croscarmellose sodium, Magnesium stearate, Sodium stearyl fumarate |
|
Coating: |
Polyvinyl alcohol, Macrogol 3350, Titanium dioxide, Talc,
Iron oxides |
|
|
Combination |
METFORMIN
(JANUMET) |
|
|
US Basic
Patent |
EP Basic
Patent |
TR Basic
Patent |
TR
Secondary Patents |
First EU
Authorisation |
Country |
|
6699871 26.07.2022 |
1412357
B1 05.07.2022 |
2006/02575
T4 05.07.2022 |
SEARCH! |
21.03.2007 |
EU |